Labsystems Diagnostics Oy


Labsystems Diagnostics Oy, based in Finland, is a pioneer in innovative diagnostic research and development for nearly 40 years. The company specializes in developing, manufacturing, and marketing high-quality diagnostic solutions for neonatal screening, infectious diseases, clinical biochemistry, and other medical fields. It is a market leader in newborn screening technology, providing comprehensive solutions including screening kits, automation, and user-friendly software. The company's mission is to develop diagnostic solutions for diseases of public health importance globally, with a vision to make healthcare affordable and accessible worldwide.

Industries

manufacturing
medical
medical-device

Nr. of Employees

medium (51-250)

Labsystems Diagnostics Oy


Products

Newborn screening kits and instruments

Reagent kits and automated or modular instrumentation designed for neonatal screening of inborn errors of metabolism and endocrine disorders using microplate and mass-spectrometry workflows.

Life sciences reagents (custom oligonucleotides and protein enzymes)

Custom oligonucleotides and research-grade protein enzymes intended for molecular biology and assay development workflows.

Infectious disease diagnostic kits

Diagnostic assays for detection of infectious agents from clinical specimens using molecular and immunoassay formats.

Gastroenterology diagnostic tests

Assays and reagents for evaluation of gastrointestinal conditions used to support clinical diagnosis and treatment planning.

Clinical diagnostics (HPLC and LC-MS/MS workflows)

Clinical diagnostic solutions leveraging HPLC and LC-MS/MS methods for precise measurement of complex biomarkers and analytes.

Point-of-care test products

Diagnostic devices and reagent tests designed for rapid testing at point-of-care settings, including newborn checks and selected clinical markers.


Services

Manufacturing of diagnostic kits and instruments

On-site production and assembly of diagnostic reagent kits and instruments across multiple modalities using automated production lines and robotics; manufacture of CE-marked neonatal and diagnostic kits for export.

Assay development and analytical R&D

Research and development of immunoassays, molecular assays, LC‑MS methods and newborn screening assays, including method verification and analytical validation.

Global distribution and partner support

Commercial distribution, partnership management and OEM relationships to supply diagnostic products and instruments to international markets.

Expertise Areas

  • Newborn screening program instrumentation and assays
  • Immunoassay development (EIA/FEIA)
  • LC-MS/MS clinical assay development
  • Molecular diagnostics for infectious disease and genetic screening
  • Show More (6)

Key Technologies

  • Liquid chromatography–mass spectrometry (LC-MS / LC-MS-MS)
  • Flow injection analysis–tandem mass spectrometry (FIA‑MS/MS)
  • Enzyme immunoassays (EIA / FEIA)
  • Fluoro-enzymatic immunoassays
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.